Monday November 20, 2017
Feb-19-2012 17:54TweetFollow @OregonNews
Deadly Conflict of Interest in Nova Scotia Over Prescription Drug Monitoring?Marianne Skolek Salem-News.com
"Our hopes are high. Our faith in the people is great. Our courage is strong. And our dreams for this beautiful country will never die." Pierre Trudeau
(MYRTLE BEACH, SC) - In July 2011, I wrote about the maker of OxyContin, Purdue Pharma, keeping the drugs flowing in Nova Scotia as a huge epidemic of death, addiction and abuse is being fought. (Link provided below). Purdue Pharma Canada made a "generous" donation to the QEII Pain Clinic in Halifax, Nova Scotia in the amount of $130,000. Their support of the treatment of chronic pain is their claim that one in five Nova Scotians suffer from chronic pain. In addition to enhancing the pain clinic, the donation from Purdue Pharma Canada will be used to expand the Nova Scotia Chronic Pain Collaborative Care Network (NSCPCCN) across Canada.
Nova Scotia has a Prescription Drug Monitoring Program in place to prevent the diversion of prescription drugs -- and the head of the program is Peter MacDougall, PhD, MD and a Staff Anesthesiologist for the QEII Health Sciences Centre as well as an Assistant Professor at Dalhousie University.
His clinical and research interests are in the area of chronic pain, particularly the development of networks between community physicians and specialists and the prevention of chronic post-operative pain syndromes. Dr. MacDougall is the Director of the Nova Scotia Chronic Pain Collaborative Care Network
There is a problem here -- and that is the good doctor heading the "Nova Scotia Chronic Pain Collaborative Chronic Pain Network (NSCPCCPN wears two hats -- and the hats may very well read "Conflict of Interest." NSCPCCN is funded by Purdue Pharma, maker of the drug crippling not only Nova Scotia, but the entire country of Canada. So the physician advising Nova Scotia on their prescription drug epidemic through the Nova Scotia Prescription Drug Monitoring Program is also the same physician working for the pain network set up by the pharmaceutical company responsible for their OxyContin epidemic in Nova Scotia.
"Purdue is pleased to continue working in partnership with educational institutions and hospital foundations in the province to support programs such as the Nova Scotia Chronic Pain Collaborative Care Network which improves patient care, as well as encourages the safe and appropriate use of medicines" said Dr. Cornelia Hentzsch, president, Purdue Pharma Canada.
It was reported this week that OxyContin is being replaced as of next month by its maker, Purdue Pharma, with the new drug OxyNeo, which is supposedly harder to crush and as a result difficult to inhale or inject by those looking to beat the controlled release formula.
Ontario and others don't buy the Purdue Pharma "undertreatment of pain" propaganda and are fighting back
There is help for Canada and, in particular Nova Scotia, and it's not coming from Purdue Pharma and their distorted version of helping fight the epidemic they created. Rather it is coming from people taking up a legitimate fight for human life.
Because of the high addiction rates to OxyContin, the Ontario Drug Benefit Program has dropped funding for both versions of Purdue Pharma's dangerous drug. Hopefully, Nova Scotia and other provinces will follow Ontario's lead sooner -- rather than later.
A woman from Nova Scotia named Amy Graves is making a difference in the tsunami of prescription drug overdoses and deaths in Canada and keeping families safe from the drug epidemic. Her website is http://gpdots.com.
There is a well organized group called "Advocates for the Reform of Prescription Opioids (ARPO). Their website is www.rxreform.org Ada Giudice-Tompson is Vice-President
Wagners Law Firm in Halifax has filed a class action suit against the maker of OxyContin for the false promotion of the drug which has resulted in an epidemic of addiction and death in Canada. Their website is http://www.wagners.co/
I encourage anyone dealing with the prescription drug epidemic in Canada, to refer to these websites and become involved. The lives of your family members may depend upon your joining forces with those who can make change. Change will not come from any pharmaceutical company such as Purdue Pharma who places their people in positions to perpetuate the drugs flowing in Canada -- thus raising their profits.
Call it what you will, but wearing two hats working for Nova Scotia as well as the company responsible for the drug epidemic -- equates to conflict of interest.
LP -- For knowing before I did that "no man is an island." Sometimes I'm just slow at picking up the signs -- thanks for the feather. I love you.
Salem-News.com Reporter Marianne Skolek, is an Activist for Victims of OxyContin and Purdue Pharma throughout the United States and Canada. In July 2007, she testified against Purdue Pharma in Federal Court in Virginia at the sentencing of their three CEO's - Michael Friedman, Howard Udell and Paul Goldenheim - who pleaded guilty to charges of marketing OxyContin as less likely to be addictive or abused to physicians and patients. She also testified against Purdue Pharma at a Judiciary Hearing of the U.S. Senate in July 2007. Marianne works with government agencies and private attorneys in having a voice for her daughter Jill, who died in 2002 after being prescribed OxyContin, as well as the voice for scores of victims of OxyContin. She has been involved in her work for the past 8-1/2 years and is currently working on a book that exposes Purdue Pharma for their continued criminal marketing of OxyContin.
Marianne is a nurse having graduated in 1991 as president of her graduating class. She also has a Paralegal certification. Marianne served on a Community Service Board for the Courier News, a Gannet newspaper in NJ writing articles predominantly regarding AIDS patients and their emotional issues. She was awarded a Community Service Award in 1993 by the Hunterdon County, NJ HIV/AIDS Task Force in recognition of and appreciation for the donated time, energy and love in facilitating a Support Group for persons with HIV/AIDS.
Articles for February 18, 2012 | Articles for February 19, 2012 | Articles for February 20, 2012